C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof

Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273)
08/2011
08/18/2011	US20110201105 Lactation-associated polypeptides
08/18/2011	US20110201044 Tuberculosis diagnostic test
08/18/2011	US20110201034 Method and kit for detecting antibody to avibacterium paragallinarum
08/18/2011	US20110200629 Tumor antigen peptide and use thereof
08/18/2011	US20110200626 Iqgap3 epitope peptides and vaccines containing the same
08/18/2011	US20110200622 Polypeptide specifically binding to vascular endothelial growth factor, fusion protein including polypeptide, and methods therefor
08/18/2011	US20110200608 Fully human antibodies to high molecular weight-melanoma associated antigen and uses thereof
08/18/2011	US20110200560 Non-ionic self-assembling peptides and uses thereof
08/18/2011	US20110200533 Compounds for the diagnosis of diseases associated with vcam expression
08/18/2011	US20110200528 Cyclized ngr peptide compounds, compositions, and methods of their use
08/18/2011	US20110200527 Peptide Ligand Directed Drug Delivery
08/17/2011	EP2357199A1 Antibody against n-terminal region of -chain of hemoglobin
08/17/2011	EP2357198A1 Opsonic and protective monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria
08/17/2011	EP2357191A2 Cyclic antimicrobial peptides
08/17/2011	EP2357190A2 Cyclic antimicrobial peptides
08/17/2011	EP2356269A2 Fibronectin type iii domain based scaffold compositions, methods and uses
08/17/2011	EP2356144A2 Composition for producing anti-amyloid beta peptide antibodies with d-peptides
08/17/2011	EP2355852A1 Chemically modified cell-penetrating peptides for improved delivery of gene modulating compounds
08/17/2011	EP2355837A1 Cycloundecadepsipeptide compounds and use of said compounds as a medicament
08/17/2011	EP1879911B1 Dye conjugates of template-fixed peptidomimetics
08/17/2011	EP1491553B1 Peptides for the treatment of cancer associated with the human papilloma virus (hpv) and other epithelial tumours
08/17/2011	CN1681845B Therapeutic uses of monoclonal antibodies to the angiotensin-II type-1 receptor
08/17/2011	CN1637416B Labelled growth hormone secretagogue and its synthesis method and uses
08/17/2011	CN102156164A Mass spectra identification method of nucleophosmin variable spliceosome and gastric cancer diagnostic reagent kit
08/17/2011	CN102153630A Ring octapeptide and preparation method and application thereof in medicament making
08/17/2011	CN102153629A Short peptide and application thereof
08/17/2011	CN102153628A Alpha1-antitrypsin polyclonal antibody and application of alpha1-antitrypsin polyclonal antibody and polypeptide for alpha1-antitrypsin polyclonal antibody
08/17/2011	CN102153627A Modifier for gelatinase A inhibitory polypeptide and preparation method thereof
08/17/2011	CN102153626A Short peptide with bacteriostatic activity and application thereof
08/17/2011	CN102153625A Dominant epitopes for identification of anti-Titin antibodies and application thereof
08/17/2011	CN102153624A Antitumor cytotoxic T lymphocyte (CTL) epitope peptide analog derived from COX-2
08/17/2011	CN102153623A Compound with thrombolytic activity and preparation method and application thereof
08/17/2011	CN102153621A B-cell epitope of NA-protein for new influenza A (H1N1) and application thereof
08/17/2011	CN102153616A Separation and purification method for cyclohexyl peptide compounds and salts thereof
08/17/2011	CN101475631B Liquid phase synthesizing method for bivalirudin
08/16/2011	US7999071 vector-based vaccine may well aid in the development of effective vaccines for a range of human cancers; nucleic acid; agonist polypeptide derived from a mucin tumor antigen; genetic vaccine
08/16/2011	US7999070 Process for screening of a binding peptide specific for specific RNA and RNA binding peptides therefrom
08/16/2011	US7999068 Process for the preparation of bicyclic peptide compounds
08/16/2011	US7998924 Compounds that bind to p185 and methods of using the same
08/16/2011	CA2615061C Peptide for antibody radio-labeling
08/16/2011	CA2490538C New assays for preimplantation factor and preimplantation factor peptides
08/16/2011	CA2405450C Dermacentor variabilis gaba-gated chloride channels
08/16/2011	CA2376164C Intermolecularly associating compounds, and aggregates comprising them
08/16/2011	CA2174928C Compositions that specifically bind to colorectal cancer cells and methods of using the same
08/11/2011	WO2011097633A2 Egf receptor mimicking peptides
08/11/2011	WO2011095769A1 Actagardine derivatives, and pharmaceutical use thereof
08/11/2011	WO2011095768A1 Lantibiotic salts
08/11/2011	WO2011095705A2 Novel caspase-14 activator peptides and compositions comprising said peptides
08/11/2011	WO2011095607A1 Template-fixed peptidomimetics with cxcr7 modulating activity
08/11/2011	WO2011095220A1 Template - fixed peptidomimetics with cxcr7 modulating activity
08/11/2011	WO2011095218A1 Template-fixed pep tidomime tics with cxcr7 modulating activity
08/11/2011	WO2011095082A1 Cyclic lipopeptide compounds, preparation methods and uses thereof
08/11/2011	WO2011034931A3 Anti-fouling paints and coatings
08/11/2011	US20110197291 Endoplasmic Reticulum Localization Signals
08/11/2011	US20110195914 Macrocyclic antiproliferation agents and methods of treatment
08/11/2011	US20110195911 Synthetic analogs of the juxtamembrane domain of igf1r and uses thereof
08/11/2011	US20110195909 Novel x-conotoxin peptides (-ii)
08/11/2011	US20110195907 Amino acid and peptide conjugates of amiloride and methods of use thereof
08/11/2011	US20110195906 Osteogenic synthetic peptides, pharmaceutical compositions comprising the same, and medium containing the same
08/11/2011	US20110195892 Artifical Pulmonary Surfactant Compositions
08/11/2011	US20110195861 Method of detecting auto-antibodies from patients suffering from rheumatoid arthritis, a peptide and an assay kit
08/11/2011	US20110195510 csPCNA Isoform Modifications And Uses Thereof
08/11/2011	US20110195494 Dll4-binging molecules
08/11/2011	US20110195452 set of sequences for targeting expression and control of the post-translational modification of a recombinant polypeptide
08/11/2011	US20110195409 Streptococcus pyogenes classification
08/11/2011	US20110195133 Dermcidin-derived peptides for lung cancer diagnostics
08/11/2011	US20110195081 Foxm1 peptide and medicinal agent comprising the same
08/11/2011	US20110195045 Methods, agents and peptides for inducing an immune response to matrix metalloproteinase-2 expressing tumors
08/11/2011	US20110195043 Dimeric Smac Mimetics
08/11/2011	CA2789164A1 Lantibiotic salts
08/11/2011	CA2789119A1 Template-fixed peptidomimetics with cxcr7 modulating activity
08/11/2011	CA2789030A1 Template - fixed peptidomimetics with cxcr7 modulating activity
08/10/2011	EP2354152A1 Peptide antagonist of interleukin-15 activity
08/10/2011	EP2352746A1 Bioactive compounds
08/10/2011	EP2352745A1 Antiviral polypeptides
08/10/2011	EP2352508A2 Muc-1 cytoplasmic domain peptides as inhibitors of cancer
08/10/2011	EP1572743B1 Peptides and their use for the treatment of hiv infections
08/10/2011	EP1358206B1 Peptide-based compounds
08/10/2011	CN1990037B Thymosin alpha1 active fragment and polyethylene glycol derivative thereof
08/10/2011	CN102149816A Novel bacteriophage and antibacterial composition comprising same
08/10/2011	CN102149725A CBP501 -derived agents and methods based thereon for inhibiting G2 cell cycle arrest and sensitizing cells to DNA damaging agents
08/10/2011	CN102149402A Cyclosporin derivatives for treating ocular and dermal diseases and conditions
08/10/2011	CN102146122A Process for producing medicament with uterine contraction effect
08/10/2011	CN102146121A Process for producing antagonist medicament containing OXT (oxytocin)
08/10/2011	CN101648993B Small peptide A with antibacterial and antitumor functions and applications thereof
08/10/2011	CN101648990B Small peptide D with antibacterial and antitumor functions and applications thereof
08/10/2011	CN101372507B Signal conotoxin mutant polypeptides compound lt14a-7, preparation and use thereof
08/09/2011	US7994285 Transmembrane cell surface receptor specific immunoglobulin for use in diagnosis and treatment of cell proliferative, cardiovascular, arthritic and diabetic disorders
08/09/2011	US7994276 Composition of tumour-associated peptides and related anti-cancer vaccine
08/09/2011	US7994148 Transmembrane delivery peptide and bio-material comprising the same
08/09/2011	US7994137 Using f-met-leu-x peptides to modify lymphocyte response to immunoglobulin-e challenge; inhibiting t-cell migration; immunotherapy
08/09/2011	US7994134 Peptide-based compounds
08/09/2011	US7994133 Isozyme-specific antagonists of protein kinase C
08/09/2011	US7994132 polypeptides that stimulate the formation and cycling of pre-beta high density lipoproteins, promote lipid transport and detoxification, inhibit osteoporosis and atherosclerosis, intensify the activity anticholesterol agents, causing them to be significantly more antiinflammatory at any given dosage
08/09/2011	US7994128 Conotoxin peptides useful as inhibitors of neuronal amine transporters
08/09/2011	CA2350340C B-cell epitopes of hsp65 and uses thereof
08/09/2011	CA2334941C Tnf-derived peptides for use in treating oedema
08/09/2011	CA2253240C Hereditary hemochromatosis gene
08/09/2011	CA2237995C Peptide conjugates derived from thymic hormones, their use as medicament and compositions containing them
08/09/2011	CA2146328C C-c ckr-1, c-c chemokine receptor

1 ... 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 ... 423